| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 5 Sep 2026 | 1 Sep 2026 |
| Molbio Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2026 inter alia to consider and approve To consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30 June 2026. The Board of Directors at their meeting held on Saturday, September 05, 2026 approved the Un-audited Financial Results (Standalone & Consolidated) for the quarter ended on June 30, 2026 (As Per BSE Announcement Dated on: 05/09/2026) | ||
| Board Meeting | 27 Aug 2026 | 27 Aug 2026 |
| Outcome of Board Meeting held on August 27, 2026, as per Reg 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations). | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.